MedPath

A Retrospective Study of COVID-19 Treatments

Completed
Conditions
Covid19
COVID-19 Respiratory Infection
COVID-19 Lower Respiratory Infection
COVID-19 Acute Bronchitis
COVID-19 Pneumonia
SARS-CoV2 Infection
SARS-CoV-2 Acute Respiratory Disease
COVID-19 Acute Respiratory Distress Syndrome
Interventions
Other: No Intervention Used
Registration Number
NCT04949230
Lead Sponsor
ProgenaBiome
Brief Summary

Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.

Detailed Description

Subjects who have recovered from COVID-19 will answer questions regarding the severity of their illness, symptoms experienced, what treatment they received, and how long they were ill.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
  2. Male or female of 18 years of age or older
  3. Diagnosis of COVID-19 infection by RT- PCR
  4. Recovery from COVID-19
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
COVID-19 PatientsNo Intervention UsedSubjects who have recovered from COVID-19
Primary Outcome Measures
NameTimeMethod
Survey ResponseOne hour

Answers given by subjects on their recovery from COVID-19

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ginger Aurella

🇺🇸

Ventura, California, United States

© Copyright 2025. All Rights Reserved by MedPath